| ISA | ALKYLATING-DRUG |
| ANCESTORS | ALKYLATING-DRUG ALL ANTINEOPLASTIC-AGENT DRUG MATERIAL OBJECT PHARMACEUTICAL-MATERIAL PHYSICAL-OBJECT THERAPEUTICAL-MATERIAL |
| carmustine | definition: alkylating anticancer drug, used in the treatment of Hodgkin's and non-Hodgkin's lymphomas, brain tumor, multiple myeloma and melanoma. Possible side effects are myelosuppression, nausea and vomiting and potential secondary neoplasia. Intravenous administration. (en) part of speech: noun term type: main entry term number: mass reliability code: 10 context (x): I_carmus.txt origination date: 19/12/2001 |
| Carmubris | commercial restriction: trade name cross-reference: definition: CARMUSTINE part of speech: noun number: mass geographical usage: USA (en) term type: synonym reliability code: 10 |
| BCNU | definition: ver carmustine (en) term type: acronym reliability code: 10 part of speech: noun number: mass context (x): I_carmus.txt origination date: 19/12/2001 |
| BiCNU | definition: Ref.cruzada con def de carmustine (en) term type: acronym reliability code: 10 part of speech: noun number: mass |
| carmustina | definition: fármaco alquilante antineoplásico, utilizado para el tratamiento del linfoma Hodgkin y no-Hodgkin, tumor cerebral, mieloma múltimple y melanoma. Los efectos secundarios más comunes son mielosupresión, nauseas y vómitos, y posibilidad de desarrollar neoplasias secundaria. Administración intravenosa. (es) term type: main entry term part of speech: noun gender: feminine number: mass reliability code: 10 context (x): E_carmus.txt origination date: 19/12/2001 |
| Nitrourean | commercial restriction: trade name cross-reference: definition: CARMUSTINE part of speech: noun number: mass geographical usage: España (es) term type: synonym gender: feminine reliability code: 10 |